Structural basis for inhibition of erythrocyte invasion by antibodies to <i>Plasmodium falciparum</i> protein CyRPA.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28195530.
- Also identified by DOI 10.7554/eLife.21347 and PMC identifier 5349848.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
<i>Plasmodium falciparum</i> causes malaria in humans with over 450,000 deaths annually. The asexual blood stage involves invasion of erythrocytes by merozoites, in which they grow and divide to release daughter merozoites, which in turn invade new erythrocytes perpetuating the cycle responsible for malaria. A key step in merozoite invasion is the essential binding of PfRh5/CyRPA/PfRipr complex to basigin, a step linked to the formation of a pore between merozoites and erythrocytes. We show CyRPA interacts directly with PfRh5. An invasion inhibitory monoclonal antibody to CyRPA blocks binding of CyRPA to PfRh5 and complex formation thus illuminating the molecular mechanism for inhibition of parasite growth. We determined the crystal structures of CyRPA alone and in complex with an antibody Fab fragment. CyRPA has a six-bladed β-propeller fold, and we identify the region that interacts with PfRh5. This functionally conserved epitope is a potential target for vaccines against <i>P. falciparum</i>.
Medical subject headings
- Antibodies, Protozoan
- Antigens, Protozoan
- Carrier Proteins
- Malaria Vaccines
- Protozoan Proteins